Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lupin
Pharma
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
AZ and Daiichi reported a positive phase 3 trial in TNBC. InnoCare and Zenas signed a potential $2 billion deal. Lupin will build a new U.S. plant.
Angus Liuu
Oct 10, 2025 10:55am
Gilead inks Biktarvy settlements with 3 generic drug makers
Oct 7, 2025 7:40am
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
Lupin recalls nearly 3,000 bottles of OCD drug in US
Apr 24, 2025 9:48am
Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia
Dec 6, 2024 9:00am
Lupin recalls 600K bottles of blood pressure med
Nov 25, 2024 1:20pm
